Authors
Djibril M Ba, Xiang Gao, Laila Al-Shaar, Joshua E Muscat, Vernon M Chinchilli, Robert B Beelman, John P Richie
Publication date
2021/11/1
Journal
Journal of affective disorders
Volume
294
Pages
686-692
Publisher
Elsevier
Description
Background
Mushrooms contain numerous bioactive compounds that may be associated with reduced anxiety including vitamin B12, nerve growth factor, antioxidants, and anti-inflammatory agents. We hypothesized that mushroom consumption is associated with a lower risk of depression in American adults.
Methods
Data from the National Health and Nutrition Examination Survey 2005–2016 was used. Up to two days of 24 h dietary recall were analyzed to assess mushroom intake frequency. Depression was measured using the Patient Health Questionnaire (PHQ-9, score ≥ 10). We used multivariable logistic regression models, adjusting for potential confounding factors.
Results
Among 24,699 participants (mean (SE) age: 45.5 (0.3) years), the weighted prevalence of depression was 5.9%. Mushrooms were consumed by 5.2% of participants. Compared with the lowest tertile of mushroom intake, participants in the …
Total citations
20212022202320243111014